Display options
Cite
van Koningsbruggen-Rietschel S. Disease-Specific Clinical Trial Networks: the Example of Cystic Fibrosis. Drug Res (Stuttg). 2018;68:S21-S23doi: 10.1055/a-0733-0883.
van Koningsbruggen-Rietschel, S. (2018). Disease-Specific Clinical Trial Networks: the Example of Cystic Fibrosis. Drug research, 68S21-S23. https://doi.org/10.1055/a-0733-0883
van Koningsbruggen-Rietschel, Silke. "Disease-Specific Clinical Trial Networks: the Example of Cystic Fibrosis." Drug research vol. 68 (2018): S21-S23. doi: https://doi.org/10.1055/a-0733-0883
van Koningsbruggen-Rietschel S. Disease-Specific Clinical Trial Networks: the Example of Cystic Fibrosis. Drug Res (Stuttg). 2018 Nov;68:S21-S23. doi: 10.1055/a-0733-0883. Epub 2018 Nov 19. PMID: 30453371.
Copy Download .nbib Format: NLM
Share it on

Drug Res (Stuttg). 2018 Nov;68:S21-S23. doi: 10.1055/a-0733-0883. Epub 2018 Nov 19.

Disease-Specific Clinical Trial Networks: the Example of Cystic Fibrosis.

Drug research

Silke van Koningsbruggen-Rietschel

Affiliations

  1. Mukoviszidose-Zentrum Köln, Pädiatrische Pneumologie und Allergologie, Klinik und Poliklinik für Kinder- und Jugendmedizin, Universität zu Köln.

PMID: 30453371 DOI: 10.1055/a-0733-0883

[No abstract available.]

Georg Thieme Verlag KG Stuttgart · New York.

Conflict of interest statement

The authors declares that she has no conflict of interest.

MeSH terms

Publication Types